PRZOOM - /newswire/ -
Guangzhou, China, 2014/12/02 - The Chinese Diabetes Society (CDS) has selected Wiley’s Diabetes/Metabolism Research and Reviews (DMMR) as its official scientific journal, marking a significant milestone for both parties - Wiley.com. NYSE: JWa, JWb
They signed a Memorandum of Understanding (MOU) in early November at CDS’ 18th Scientific Meeting in Guangzhou.
The MOU formalises a partnership which commenced 18 months ago establishing an editorial board to publish the first DMMR-CDS China issue, which went online in October 2014 under an independent educational grant from AstraZeneca China. Selected abstracts from CDS’ 18th Scientific Meeting have just been published as a supplement of DMRR in November 2014. Papers are now being called for the second China special issue of DMRR.
As CDS’ official scientific journal, DMRR will publish CDS clinical guidelines and consensus statements. The CDS logo will now appear on the DMRR journal cover. Besides promoting DMRR as its only official journal, CDS will encourage submissions to DMRR. Prof Ji Linong, as the CDS representative, will serve as an Editor of DMRR. During the MOU ceremony, Prof Jianping Weng, Chairman of CDS, stated that he believed this was the first collaboration of its kind in China.
Over the years, CDS, an organization under the Chinese Medical Association, has grown in stature for advancing its work in diabetes research. Its annual scientific meeting held in Guangzhou earlier this year attracted some 7,000 attendees. A similar number attended the meeting online.
DMRR, is published by Wiley (wiley.com) on behalf of UK Diabetes and has an Impact Factor: 3.593 and ISI Journal Citation Reports © Ranking: 2013: 45/123 Endocrinology & Metabolism.
‘We’re extremely honoured to work with CDS and are grateful for the support and recognition they have given, in choosing the Diabetes/Metabolism Research and Reviews as their official journal, ’ said Martine Docking, Commercial Director, Asia-Pacific. ‘We share a common goal with CDS. We aim to bring the best of clinical and professional content to the diabetes medical community in China and bring the best of diabetes research from China to our international reader audience.’
Prof Jianping Weng, Chairman of CDS, said, ‘I’m satisfied with the cooperation between your esteemed journal and the Society. We wish to further expand our all-round cooperation with DMRR for mutual benefits. I believe such a strategic cooperation will definitely elevate our win-win relations.’
According to findings released by the Journal of the American Medical Association last September, 11.6 per cent of adults (or 114 million) in China have diabetes. This number is set to increase with 40 per cent of 18 to 29 year olds on the brink of developing the disease.
The International Diabetes Federation has estimated that there are 371 million people worldwide with the disease, including 98.4 million in China.